Ru-Fong Cheng

Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy…

Menopause · 2013 · 41 citations

Desvenlafaxine 50 and 100 mg/d versus placebo for the treatment of major depressive disorder: a phase 4, randomized controlled trial

The Journal of Clinical Psychiatry · 2015 · 29 citations